AndrewE.: Evaluation of the vascular clinical trial program of metrizamide and iohexol Acta radiol. Diagnosis25 (1984), 59.
2.
AndrewE.DahlströmK.SveenK.RenaaT.: Amipaque (metrizamide) in vascular use and use in body cavities. A survey of the initial clinical trials. Invest. Radiol.16 (1981), 455.
3.
BadgleyR. F.: An assessment of research methods reported in 103 scientific articles from two Canadian medical journals. Canad. Med. Ass. J.85 (1961), 246.
4.
DersimonianR.CharetteL. J.McPeekB.MostellerF.: Reporting on methods in clinical trials. New Engl. J. Med.306 (1982), 1332.
5.
FriedmanL. M.FurbergC. D.DemetsD. L.: Fundamentals of clinical trials. John Wright. PSG Inc.. Boston, Bristol, London1981.
6.
HemminkiE.: Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish Control Authorities. Europ. J. Clin. Pharmacol.19 (1981), 157.
7.
JonssonC. O.MårtensS. och Sjöqvist F.: Synpunkter på klinisk prövning av läkemedel — Speciellt psykofarmaka. (In Swedish.)Nord. psykiat. T.23 (1969), 281.
8.
LionelN. D. W.HerxheimerA.: Assessing reports of therapeutic trials. Brit. Med. J.3 (1970), 637.
9.
MahonW. A.DanielE. E.: A method for the assessment for reports of drug trials. Canad. Med. Ass. J.90 (1964), 565.
10.
MostellerF.GilbertP. J.McPeekB.: Reporting standards and research strategies for controlled trials. Controlled clin. Trials1 (1980), 37.
11.
ReiffensteinR. J.SchiltrothA. J.ToddD. M.: Current standards in reported drug trials. Canad. Med. Ass. J.99 (1968), 1134.
12.
WechslerH.GrosserG. H.GreenblattM.: Research evaluating antidepressant medications on hospitalized mental patients. A survey of published reports during a five-year period. J. Nerv. Ment. Dis.141 (1965), 231.
